FDA Grants Intravesical Immunotherapy Priority Review for Bladder Cancer
The FDA has assigned a priority review designation to the intravesical immunotherapy MCNA as a treatment for patients with high-risk non-muscle invasive bladder cancer following first-line bacillus Calmette-Guerin therapy.
New FIRE-3 Analysis Shows Importance of Subsequent Therapies on mCRC Outcomes
Sequence of therapies may be more significant versus single agents in treating patients with metastatic colorectal cancer.
Checkpoint Inhibitors Show Promise in Triple-Negative Breast Cancer
Immune checkpoint inhibitors can be of significant value in combatting recurrent and metastatic triple negative breast cancer, Rita Nanda, MD, told physicians at the recent 14th Annual International Congress on the Future of Breast Cancer.
Adjuvant Trastuzumab Benefit Elucidated in Small HER2-Positive Breast Cancer
Patients with HER2-positive breast cancer that was ≤2 cm experienced a substantial improvement in disease-free and overall survival when treated with adjuvant trastuzumab.
Second Study Proves Daratumumab's Efficacy in Multiple Myeloma
Findings from a second phase II clinical trial have demonstrated impressive signs of clinical activity with the anti-CD38 monoclonal antibody daratumumab as a monotherapy for patients with heavily pretreated multiple myelom.
Multidisciplinary Approach Key to Radium-223 Treatment for Metastatic Prostate Cancer
Radium-223 dichloride (Xofigo) has shown a significant survival advantage in treating patients with metastatic castration-resistant prostate cancer who have symptomatic bone metastases.
Radium-223 Poised to Move Beyond Prostate Cancer
The alpha particle–emitting radiopharmaceutical radium-223 (Xofigo) is set to expand beyond prostate cancer, given the agent’s potent efficacy and mild toxicity profile for patients with osteoblastic metastases.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2015
Intellisphere, LLC. All Rights Reserved.